Literature DB >> 6728904

Effect of biological time on the determination of the LD50 of 5-fluorouracil in mice.

E R Burns, S S Beland.   

Abstract

The LD50 was determined for 5-fluorouracil (FU) in mice at 11.00 and 23.00 h during one 24-hour period. These times were chosen because in mice kept on a light-dark cycle, with lights on from 06.00 to 18.00 h, the natural circadian rhythm in DNA synthetic activity in many different normal organs attains peak levels around 24.00 h (mid-dark) and through levels around 12.00 h (mid-light). The LD50 of FU, in milligrams per kilogram body weight, was much higher (450-500 mg/kg) at 11.00 than at 23.00 h (250-300 mg/kg). Since the biology of the living animal oscillates significantly on a daily or circadian basis, it is understandable that the degree of susceptibility or resistance to drugs should also fluctuate over the circadian period. Determination of the LD50 of a drug at that point in time when the animal is naturally resistant to that drug will result is a false appraisal of the toxic effects to the drug. To assess correctly the risk a drug poses, it should be tested at its time of maximal susceptibility in the living animal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728904     DOI: 10.1159/000137977

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  8 in total

Review 1.  Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.

Authors:  R L Poorter; P J Bakker; C H Veenhof
Journal:  Pharm World Sci       Date:  1998-04

2.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  The effect of abolition of the endogenous corticosteroid rhythm on the circadian variation in methotrexate toxicity in the rat.

Authors:  J English; G W Aherne; J Arendt; V Marks
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5-16) in advanced colorectal cancer patients.

Authors:  Edmondo Terzoli; Carlo Garufi; Albina Rita Zappalà; Barbara Vanni; Patrizia Pugliese; Giancarlo Antonini Cappellini; Anna Maria Aschelter; Maria Perrone; Diana Giannarelli
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

5.  Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patients.

Authors:  G A Bjarnason; I G Kerr; N Doyle; M Macdonald; M Sone
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 6.  The daily timing of gene expression and physiology in mammals.

Authors:  Ueli Schibler
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

7.  Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut.

Authors:  S P Bach; S E Williamson; S T O'Dwyer; C S Potten; A J M Watson
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

8.  Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice.

Authors:  Judith Sommer; Abdo Mahli; Kim Freese; Tobias S Schiergens; Fulya Suzan Kuecuekoktay; Andreas Teufel; Wolfgang E Thasler; Martina Müller; Anja K Bosserhoff; Claus Hellerbrand
Journal:  Oncotarget       Date:  2017-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.